Crispr Therapeutics AG leverages CASGEVY's rollout, a robust pipeline in cardiovascular, oncology, & partnerships to large ...

Enlicitide decanoate demonstrated meaningful LDL lowering in patients with heterozygous familial hypercholesterolemia and ...

According to a new study inclisiran, given as a twice-yearly injection, significantly lowers LDL cholesterol in low-risk patients who are not on any lipid-lowering treatment at present. This ...

Medtronic plc received U.S. FDA approval for its Omniasecure defibrillation lead for placement in the right ventricle to ...

A new method, based on the use of molecules known as polypurine hairpins, facilitates the uptake of cholesterol by cells and ...

When the amount of cholesterol in the blood is too high, hypercholesterolemia can develop, causing serious damage to the ...

When the amount of cholesterol in the blood is too high, hypercholesterolemia can develop, causing serious damage to the ...

Topline data were announced from two phase 3 trials evaluating enlicitide decanoate for the treatment of adults with hyperlipidemia.

Smoky air often has obvious short-term health effects like coughing and sore throat, but it can also have long-term impacts ...

Dr. Cissy Kityo Mutuluuza is a physician, epidemiologist, medical researcher, and the executive director of the Joint ...

Merck (MRK) stock was on the move Monday after the healthcare company announced positive results from two Phase 3 clinical trials. These studies saw meaningful reductions in LDL-C from patients with ...